Scottish Brain Sciences (SBS), a leading clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer’s disease and other neurodegenerative conditions, has opened a new state-of-the-art clinical research centre at ONE BioHub, Aberdeen.
The new clinical research centre will enable people living with Alzheimer’s disease, and those concerned with memory issues, to participate in studies focused on the early detection and treatment of Alzheimer’s and other neurodegenerative conditions.
The clinical research centre at ONE BioHub becomes SBS’s third research facility, complementing the Company’s research hub in St Andrews and its Edinburgh headquarters. The new facility will allow SBS to conduct clinical studies focused on early diagnosis, intervention, and precision trials to advance the global understanding and treatment of Alzheimer’s and related disorders.
By establishing a presence within ONE BioHub, a launchpad for start-ups and high potential life science companies looking to rapidly scale and grow, SBS joins a growing network of research-driven companies including NovaBiotics and Genomes.io already based at ONE BioHub. From ONE BioHub, SBS will play a central role in connecting brain health research with clinical and commercial pathways, strengthening Scotland’s position as an international hub for brain health innovation and further contributing to the country’s wider life-sciences growth strategy.
The Aberdeen site was officially opened on 14 November by Aberdeen-based research participant, Lynne Carroll and was also attended by Richard Lochhead MSP, Minister for Business and Employment, who will highlight SBS’s investment as a boost to Scotland’s innovation economy and public health landscape. Pictured above are (l-r): Professor Craig Ritchie, CEO and Founder, SBS; Dr Deborah O’Neil OBE FRSE, Chair, ONE Life Sciences and BioAberdeen Ltd; Lynne Carroll, Scottish Brain Sciences research participant; Richard Lochhead MSP, Minister for Business and Employment.
Professor Craig Ritchie, CEO and Founder of Scottish Brain Sciences, said: “The people of the north-east deserve early access to breakthroughs in brain health and dementia research. This new site will help ensure that people here can take part in trials, receive advanced assessments, and contribute to discoveries that could change the future of Alzheimer’s disease. Inviting one of our research participants to officially open this centre reflects our belief that progress begins and ends with the people who volunteer to take part. They are the beating heart of discovery.”